Ipsen SA Valuation
| IPSEY Stock | USD 44.14 3.68 9.10% |
At this time, the firm appears to be overvalued. Ipsen SA ADR retains a regular Real Value of $32.86 per share. The prevalent price of the firm is $44.14. Our model calculates the value of Ipsen SA ADR from evaluating the firm fundamentals such as Return On Equity of 0.19, current valuation of 8.28 B, and Return On Asset of 0.1 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ipsen SA's price fluctuation is very steady at this time. Calculation of the real value of Ipsen SA ADR is based on 3 months time horizon. Increasing Ipsen SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ipsen SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ipsen Pink Sheet. However, Ipsen SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 44.14 | Real 32.86 | Hype 40.46 |
The intrinsic value of Ipsen SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Ipsen SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Ipsen SA ADR helps investors to forecast how Ipsen pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ipsen SA more accurately as focusing exclusively on Ipsen SA's fundamentals will not take into account other important factors: About Ipsen SA Valuation
Our relative valuation model uses a comparative analysis of Ipsen SA. We calculate exposure to Ipsen SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ipsen SA's related companies.Ipsen S.A. operates as a biopharmaceutical company worldwide. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen SA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4500 people.
8 Steps to conduct Ipsen SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ipsen SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ipsen SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ipsen SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ipsen SA's revenue streams: Identify Ipsen SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ipsen SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ipsen SA's growth potential: Evaluate Ipsen SA's management, business model, and growth potential.
- Determine Ipsen SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ipsen SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Ipsen SA Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 82.6 M | |
| Quarterly Earnings Growth Y O Y | -0.256 | |
| Forward Price Earnings | 11.534 | |
| Retained Earnings | 648.6 M |
Additional Tools for Ipsen Pink Sheet Analysis
When running Ipsen SA's price analysis, check to measure Ipsen SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ipsen SA is operating at the current time. Most of Ipsen SA's value examination focuses on studying past and present price action to predict the probability of Ipsen SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ipsen SA's price. Additionally, you may evaluate how the addition of Ipsen SA to your portfolios can decrease your overall portfolio volatility.